Application of ICG Fluorescence Cholangiography in Laparoscopic Living Donor Left Lateral Sectionectomy

Fudan University

Status: Completed

Conditions: Living Donor Liver Transplantation

Treatments: Procedure: indocyanine green (ICG) fluorescence cholangiography

Study type: Interventional

Funder types: Other

Identifiers

NCT05506020

Huashan009

Details and patient eligibility

About

The purpose of this study was to assess the effects of indocyanine green (ICG) fluorescence cholangiography during laparoscopic left lateral sectionectomy (LLLS) on the occurrence of biliary complications in both donors and recipients in living donor liver transplantation (LDLT) and to explore the optimal dose and injection time of ICG.

Full description

This was a retrospective cohort study. The purpose of this study was to assess the effects of indocyanine green (ICG) fluorescence cholangiography during LLLS on the occurrence of biliary complications in both donors and recipients. The optimal dose and injection time of ICG were also investigated. From October 2016 to May 2022, the clinical data of 85 donors who underwent LLLS and relevant recipients in the Department of General Surgery of Huashan Hospital were retrospectively analyzed. According to whether ICG fluorescence cholangiography was used, they were divided into a non-ICG group (n=46) and an ICG group (n=39). Biliary complications were observed and the optimal dose and injection time of ICG were explored.

Enrollment: 85 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. From October 2016 to May 2022, donors and their corresponding recipients underwent laparoscopic donor liver acquisition surgery in the general surgery department of Huashan Hospital.
2. Donor age ≥ 18 years old, regardless of gender; The receptor is the corresponding receptor of the donor, and the age and sex of the receptor are unlimited.
3. The medical history is complete, which can meet the requirements of this study.
4. Volunteer to participate in this study.

Exclusion criteria

1. The medical history is incomplete, which cannot meet the requirements of this study.
2. The donor or recipient expressly refused to participate in this study.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

85 participants in 2 patient groups

ICG group

Experimental group

Description:

indocyanine green (ICG) fluorescence cholangiography

Treatment:

Procedure: indocyanine green (ICG) fluorescence cholangiography

non ICG group

No Intervention group

Description:

no intervention